http://www.mail.com/companies/25114-johnson-johnson.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/companies/25114-johnson-johnson.html http://www.mail.com/scitech/health/2096946-consumer-group-flags-high-spf-ratings-sunscreen.html WASHINGTON (AP) — Sunbathers headed to the beach this summer will find new sunscreen labels on store shelves that are designed to make the products more effective and easier to use. But despite those long-awaited changes, many sunscreens continue to carry SPF ratings that some experts consider misleading and potentially dangerous, according to a consumer watchdog group. ... Mon, 20 May 2013 03:45:52 GMT http://www.mail.com/scitech/health/2096946-consumer-group-flags-high-spf-ratings-sunscreen.html 2013-05-20T03:45:52Z http://www.mail.com/scitech/health/2058640-decades-old-question-antibacterial-soap-safe.html WASHINGTON (AP) — It's a chemical that's been in U.S. households for more than 40 years, from the body wash in your bathroom shower to the knives on your kitchen counter to the bedding in your baby's basinet. But federal health regulators are just now deciding whether triclosan — the germ-killing ingredient found in an estimated 75 percent of antibacteria... Fri, 03 May 2013 03:04:16 GMT http://www.mail.com/scitech/health/2058640-decades-old-question-antibacterial-soap-safe.html 2013-05-03T03:04:16Z http://www.mail.com/business/economy/2036612-irelands-elan-rejects-royalty-pharma-takeover-bid.html DUBLIN (AP) — The board of Irish drugmaker Elan has unanimously rejected a takeover bid from Royalty Pharma, saying the U.S. investment company's offer of $11.25 a share is much too low. Royalty last week lowered its bid for Elan from an original $12 per share offer, pricing in the result of a $1 billion share buyback by Elan. Elan chairman Robert Ingram ... Mon, 22 Apr 2013 15:14:14 GMT http://www.mail.com/business/economy/2036612-irelands-elan-rejects-royalty-pharma-takeover-bid.html 2013-04-22T15:14:14Z http://www.mail.com/business/economy/2022746-jj-1q-profit-falls-10-pct-despite-higher-sales.html Johnson & Johnson's first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration, plus charges for litigation and other items. The maker of No More Tears baby shampoo, prescription drugs and surgical tools said Tuesday repeatedly during a conference call with analysts that re... Tue, 16 Apr 2013 20:17:59 GMT http://www.mail.com/business/economy/2022746-jj-1q-profit-falls-10-pct-despite-higher-sales.html 2013-04-16T20:17:59Z http://www.mail.com/business/finance/2022724-futures-higher-wake-dows-worst-day-2013.html NEW YORK (AP) — U.S. stock futures rebounded sharply Tuesday after the Dow's worst day this year, with more U.S. corporations putting up strong quarterly numbers and more evidence of a recovery in housing. Gold prices, which hit two-year lows Monday, bounced back early Tuesday, though a sell-off in energy futures continued. Dow Jones industrial futures ro... Tue, 16 Apr 2013 13:00:31 GMT http://www.mail.com/business/finance/2022724-futures-higher-wake-dows-worst-day-2013.html 2013-04-16T13:00:31Z http://www.mail.com/entertainment/lifestyle/2020264-heir-to-johnson-johnson-wealth-buried-poland.html WROCLAW, Poland (AP) — Barbara Piasecka Johnson, a former maid who married the American heir to the Johnson & Johnson fortune, was buried Monday in her hometown in Poland after a modest funeral. An art collector and philanthropist, Johnson died at age of 76 on April 1 near Wroclaw, in southwestern Poland. She lived and studied art history in Wroclaw befor... Mon, 15 Apr 2013 16:18:24 GMT http://www.mail.com/entertainment/lifestyle/2020264-heir-to-johnson-johnson-wealth-buried-poland.html 2013-04-15T16:18:24Z http://www.mail.com/scitech/news/2020238-abbott-laboratories-recalls-blood-glucose-meters.html ABBOTT PARK, Ill. (AP) — Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels. The Abbott Park, Ill., company says the meters will display and store readings for blood glucose levels of 1,024 milligrams per deciliter or higher a... Mon, 15 Apr 2013 11:35:33 GMT http://www.mail.com/scitech/news/2020238-abbott-laboratories-recalls-blood-glucose-meters.html 2013-04-15T11:35:33Z http://www.mail.com/business/economy/2005498-stocks-edge-higher-earnings-reports.html NEW YORK (AP) — Investors are having a hard time making up their minds. The stock market extended its longest period of indecision in nearly 15 years Monday. For nearly three weeks, the Dow Jones industrial average has alternated between gains and losses, the longest such streak since July 1998. The flip-flopping follows a decisively s... Mon, 08 Apr 2013 22:25:25 GMT http://www.mail.com/business/economy/2005498-stocks-edge-higher-earnings-reports.html 2013-04-08T22:25:25Z http://www.mail.com/business/economy/1997546-heir-to-johnson-johnson-fortune-dies-76.html WARSAW, Poland (AP) — She was a Polish farmer's daughter who emigrated to the United States, a maid who worked for a wealthy American heir, and a third wife who inherited much of the Johnson & Johnson fortune after a sensational court battle with her six stepchildren. Barbara Piasecka Johnson, the widow of J. Seward Johnson Sr., heir to millions made from... Thu, 04 Apr 2013 16:26:26 GMT http://www.mail.com/business/economy/1997546-heir-to-johnson-johnson-fortune-dies-76.html 2013-04-04T16:26:26Z http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine. The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects an estimated 26 million Americans. The once-a-day medicatio... Fri, 29 Mar 2013 19:39:49 GMT http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html 2013-03-29T19:39:49Z http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday. Interpol's newly created Pharmaceutical Crime Program aims to help health agencies, police and customs bureaus in countries around th... Tue, 12 Mar 2013 11:29:37 GMT http://www.mail.com/business/economy/1948036-drugmakers-interpol-ramp-up-fight-fakes.html 2013-03-12T11:29:37Z http://www.mail.com/scitech/health/1941428-damages-awarded-jjs-depuy-hip-implant-case.html LOS ANGELES (AP) — A jury on Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson's DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip implant that was later recalled. Jurors found the ASR XL implant caused metal poisoning and other health problems suffered by Loren Kransky, 65, after he underwent surgery in 20... Fri, 08 Mar 2013 20:35:14 GMT http://www.mail.com/scitech/health/1941428-damages-awarded-jjs-depuy-hip-implant-case.html 2013-03-08T20:35:14Z http://www.mail.com/business/finance/1933848-dow-hits-record-erasing-great-recession-losses.html NEW YORK (AP) — The stock market is back. Five and a half years after the start of a frightening drop that erased $11 trillion from stock portfolios and made investors despair of ever getting their money back, the Dow Jones industrial average has regained all the losses suffered during the Great Recession and reached a new high. The blue-chip index rose 1... Wed, 06 Mar 2013 05:07:24 GMT http://www.mail.com/business/finance/1933848-dow-hits-record-erasing-great-recession-losses.html 2013-03-06T05:07:24Z http://www.mail.com/business/economy/1893182-jj-recalls-thousands-faulty-hip-implants.html TRENTON, N.J. (AP) — Johnson & Johnson has again recalled thousands of its hip implants, 2 1/2 years after the problem-plagued health care giant issued a recall of two other types of its artificial hips. Spokeswomen for J&J's DePuy Orthopaedics unit said Thursday that the company recalled the "Adept" brand all-metal total hip replacement system starting l... Thu, 14 Feb 2013 23:01:17 GMT http://www.mail.com/business/economy/1893182-jj-recalls-thousands-faulty-hip-implants.html 2013-02-14T23:01:17Z http://www.mail.com/scitech/news/1892412-report-jj-recalls-thousands-hip-implants.html TRENTON, N.J. (AP) — Johnson & Johnson has again recalled thousands of its hip implants, 2 1/2 years after the problem-plagued health-care giant issued a recall of two other types of its artificial hips. Spokeswomen for J&J's DePuy Orthopaedics unit said Thursday that the company recalled the "Adept" brand all-metal total hip replacement system starting l... Thu, 14 Feb 2013 21:59:19 GMT http://www.mail.com/scitech/news/1892412-report-jj-recalls-thousands-hip-implants.html 2013-02-14T21:59:19Z http://www.mail.com/business/economy/1887102-greek-prosecutors-bring-charges-depuy-deals.html ATHENS, Greece (AP) — Greek prosecutors have brought criminal corruption charges related to state hospital purchases from DePuy, a subsidiary of U.S. healthcare giant Johnson & Johnson. Court officials said Tuesday that five DePuy officials have been charged with bribery and money laundering over deals between 1998 and 2006. The names of the five were not... Tue, 12 Feb 2013 18:49:00 GMT http://www.mail.com/business/economy/1887102-greek-prosecutors-bring-charges-depuy-deals.html 2013-02-12T18:49:00Z http://www.mail.com/business/economy/1877784-thousands-women-sue-surgical-mesh.html ATLANTA (AP) — Soon after her surgery, Susan Harrison had a string of infections that caused intense pain, leaving her weak and unable to pick up and play actively with her young grandchildren. The discomfort and fatigue often kept her from her job as a kindergarten classroom assistant. For years, Harrison thought it was just an unfortunate consequence of... Fri, 08 Feb 2013 15:41:00 GMT http://www.mail.com/business/economy/1877784-thousands-women-sue-surgical-mesh.html 2013-02-08T15:41:00Z http://www.mail.com/scitech/health/1873656-whooping-cough-strain-us-raises-questions.html NEW YORK (AP) — Researchers have discovered the first U.S. cases of whooping cough caused by a germ that may be resistant to the vaccine. Health officials are looking into whether cases like the dozen found in Philadelphia might be one reason the nation just had its worst year for whooping cough in six decades. The new bug was previously reported in Japa... Wed, 06 Feb 2013 21:49:00 GMT http://www.mail.com/scitech/health/1873656-whooping-cough-strain-us-raises-questions.html 2013-02-06T21:49:00Z http://www.mail.com/scitech/health/1846852-trial-under-way-la-hip-joint-replacement-suit.html LOS ANGELES (AP) — A California jury heard opening statements Friday in a lawsuit that accuses Johnson & Johnson of knowingly marketing a faulty hip implant that lawyers say left thousands of people with crippling problems or in need of replacement surgeries. The fraud and negligence suit is the first of thousands of similar cases to reach trial in the Un... Sat, 26 Jan 2013 01:59:00 GMT http://www.mail.com/scitech/health/1846852-trial-under-way-la-hip-joint-replacement-suit.html 2013-01-26T01:59:00Z http://www.mail.com/business/economy/1837340-jj-4q-profit-jumps-higher-sales-lower-charges.html Higher sales of prescription drugs and medical devices helped Johnson & Johnson post a much bigger fourth-quarter profit than a year ago, when a slew of charges depressed results. However, consumer health product sales dipped and the company again pushed back its timeline for returning recalled products to stores. In addition, J&J's 2013 profit forecast, ... Tue, 22 Jan 2013 22:33:00 GMT http://www.mail.com/business/economy/1837340-jj-4q-profit-jumps-higher-sales-lower-charges.html 2013-01-22T22:33:00Z http://www.mail.com/business/economy/1837664-us-stocks-rise-tech-industrial-earns-roll.html Strong earnings reports from big U.S. companies helped push the Dow Jones industrial average to its eighth gain in nine sessions Tuesday. DuPont, Verizon and Travelers Cos., three of the 30 stocks that make up the Dow, closed higher after reporting their financial results for the final quarter of 2012. The Dow closed up 62.51 points, or 0.5 percent, at 13... Tue, 22 Jan 2013 20:49:00 GMT http://www.mail.com/business/economy/1837664-us-stocks-rise-tech-industrial-earns-roll.html 2013-01-22T20:49:00Z http://www.mail.com/business/economy/1837934-stocks-waver-companies-report-mixed-earnings.html Stocks are wavering between small gains and losses as several big U.S. companies report their fourth-quarter financial results. The Dow Jones industrial average was up four points at 13,654 shortly before noon Tuesday. The Standard & Poor's 500 index fell two to 1,484. The Nasdaq composite average dropped 10 points to 3,124. Chemical and bioscience compan... Tue, 22 Jan 2013 15:57:00 GMT http://www.mail.com/business/economy/1837934-stocks-waver-companies-report-mixed-earnings.html 2013-01-22T15:57:00Z http://www.mail.com/business/economy/1837604-stocks-open-mixed-earnings-reports-roll.html Stocks are wavering in early trading on Wall Street as U.S. companies turn in a mixed batch of earnings reports. The Dow Jones industrial average fell four points to 13,653 shortly after the opening bell Tuesday. The Standard & Poor's 500 index was down less than a point at 1,485 and the Nasdaq composite edged up a point to 3,136. ... Tue, 22 Jan 2013 13:45:00 GMT http://www.mail.com/business/economy/1837604-stocks-open-mixed-earnings-reports-roll.html 2013-01-22T13:45:00Z http://www.mail.com/business/economy/1837386-us-futures-mixed-corporate-earnings-reports.html NEW YORK (AP) — Stock futures are mixed with U.S. companies posting varying quarterly results. Dow Jones industrial futures are down 18 points to 13,558. The broader S&P futures have added 1.6 points to 1,477.30. Nasdaq futures are up a point to 2,734.75. Verizon posted a wider loss for the fourth quarter Tuesday, and DuPont said weakness in electronics a... Tue, 22 Jan 2013 12:27:00 GMT http://www.mail.com/business/economy/1837386-us-futures-mixed-corporate-earnings-reports.html 2013-01-22T12:27:00Z http://www.mail.com/scitech/health/1793144-fda-approves-1st-tuberculosis-drug-40-years.html WASHINGTON (AP) — The Food and Drug Administration on Monday approved a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades. The agency approved J&J's pill, Sirturo, for use with older drugs to fight a hard-to-treat strain of tuberculosis that has not responded to other medications. Ho... Tue, 01 Jan 2013 03:05:00 GMT http://www.mail.com/scitech/health/1793144-fda-approves-1st-tuberculosis-drug-40-years.html 2013-01-01T03:05:00Z http://www.mail.com/scitech/health/1774436-amgen-to-pay-762m-settlement-drug-marketing.html Amgen Inc. has agreed to pay $762 million to resolve federal litigation accusing the drugmaker of marketing the anemia treatment Aranesp for unapproved uses. The Thousand Oaks, Calif., company pleaded guilty Tuesday to illegally introducing a misbranded drug into interstate commerce and will pay a $136 million fine and a $14 million forfeiture, according ... Tue, 18 Dec 2012 21:47:00 GMT http://www.mail.com/scitech/health/1774436-amgen-to-pay-762m-settlement-drug-marketing.html 2012-12-18T21:47:00Z http://www.mail.com/scitech/health/1760836-lilly-plans-study-alzheimers-drug.html INDIANAPOLIS (AP) — Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a few more years to learn whether regulators will allow the drugmaker to sell it. Lilly said Wednesday that it will launch another late-stage study of the drug, solanezumab, no later than ne... Wed, 12 Dec 2012 20:42:00 GMT http://www.mail.com/scitech/health/1760836-lilly-plans-study-alzheimers-drug.html 2012-12-12T20:42:00Z http://www.mail.com/scitech/health/1756588-fda-expands-approval-jj-prostate-cancer-drug.html WASHINGTON (AP) — The Food and Drug Administration on Monday expanded approval of Johnson & Johnson's prostate cancer pill Zytiga for men with an earlier stage of the disease. The agency says Zytiga is now approved for late-stage prostate cancer patients who have not yet received chemotherapy, based on study results showing it can extend life by up to fiv... Mon, 10 Dec 2012 19:08:00 GMT http://www.mail.com/scitech/health/1756588-fda-expands-approval-jj-prostate-cancer-drug.html 2012-12-10T19:08:00Z http://www.mail.com/scitech/news/1739266-alzheimers-drug-studies-offer-patients-hope.html TRENTON, N.J. (AP) — For Alzheimer's patients and their families, desperate for an effective treatment for the epidemic disease, there's hope from new studies starting up and insights from recent ones that didn't quite pan out. If the new studies succeed, a medicine that slows or even stops progression of the brain-destroying disease might be ready in thr... Mon, 03 Dec 2012 10:48:00 GMT http://www.mail.com/scitech/news/1739266-alzheimers-drug-studies-offer-patients-hope.html 2012-12-03T10:48:00Z http://www.mail.com/business/economy/1733992-jj-board-picks-ceo-to-replace-retiring-chairman.html NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson Chairman Bill Weldon will step down from that post in late December and the world's biggest maker of health products has picked new CEO Alex Gorsky to replace him. The New Brunswick, N.J., company had named Gorsky, 52, as CEO earlier this year, replacing Weldon. J&J said Friday that Weldon will step down Dec. 2... Fri, 30 Nov 2012 17:23:00 GMT http://www.mail.com/business/economy/1733992-jj-board-picks-ceo-to-replace-retiring-chairman.html 2012-11-30T17:23:00Z